These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5684703)

  • 1. [The use of Oradexon (dexamethasone) in the management of inflammatory eye diseases].
    Hiller H
    Dtsch Gesundheitsw; 1968 Aug; 23(31):1479-83. PubMed ID: 5684703
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of a new corticosteroid in some aspecific inflammatory ocular diseases: dexamethasone 21-(pyridine-4-carboxylate)].
    Balestrazzi E; Scorcia G; Ranieri G
    Ann Ottalmol Clin Ocul; 1971 Jan; 97(1):15-22. PubMed ID: 5122645
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the ocular anti-inflammatory activity of steroidal and nonsteroidal compounds in the rat.
    Bhattacherjee P; Williams RN; Eakins KE
    Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1143-6. PubMed ID: 6874278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An anti-phlogistic effect of BCP (5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine) on experimentally induced ocular inflammation].
    Asayama R; Tsukahara I; Sakaue E; Fukuchi S; Suga K
    Nihon Ganka Kiyo; 1966 Feb; 17(2):89-101. PubMed ID: 6006623
    [No Abstract]   [Full Text] [Related]  

  • 5. A trial of 'lacribase', a new ophthalmic vehicle.
    Maclure GM
    Br J Clin Pract; 1967 Aug; 21(8):397-400. PubMed ID: 6076263
    [No Abstract]   [Full Text] [Related]  

  • 6. Ophthalmic use of topical corticosteroids.
    Angra SK
    Indian J Ophthalmol; 1982 Jul; 30(4):213-8. PubMed ID: 7166392
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.
    Smith JR; Levinson RD; Holland GN; Jabs DA; Robinson MR; Whitcup SM; Rosenbaum JT
    Arthritis Rheum; 2001 Jun; 45(3):252-7. PubMed ID: 11409666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Principles of drug therapy of inflammatory eye diseases].
    Nesterov AP
    Vestn Oftalmol; 1997; 113(1):3-5. PubMed ID: 9133041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical efficacy of medrysone, a new ophthalmic steroid.
    Dorsch W; Thygeson P
    Am J Ophthalmol; 1968 Jan; 65(1):74-5. PubMed ID: 5638193
    [No Abstract]   [Full Text] [Related]  

  • 10. Subconjunctival steroids and corneal hypersensitivity.
    Olson CL
    Arch Ophthalmol; 1966 May; 75(5):651-8. PubMed ID: 5936370
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of the glucocorticoid Oradexon on endotoxin-induced peritoneal cell response.
    Szakács J; Lázár G; Lázár G; Husztik E
    Acta Physiol Hung; 2000; 87(2):161-6. PubMed ID: 11205964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of antimicrobial preparation, decamethotoxin, for treatment of pyo-inflammatory diseases of the anterior segment of the eye].
    Titenko KS; Lovlia GD; Volianskiĭ IuL; Paliĭ KG
    Oftalmol Zh; 1977; 32(3):217-21. PubMed ID: 876602
    [No Abstract]   [Full Text] [Related]  

  • 13. [Considerations on the use of corticoids by ionization in certain ocular diseases].
    Lachaud JP
    Bull Soc Ophtalmol Fr; 1965 Jan; 65(1):84-9. PubMed ID: 5827464
    [No Abstract]   [Full Text] [Related]  

  • 14. [New ophthalmologic ointment with glucocorticoid contents].
    Novotný P
    Cas Lek Cesk; 1971 Oct; 110(42):988-9. PubMed ID: 5114562
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of topical non-steroidal anti-inflammatory drugs to steroids for control of post cataract inflammation.
    Brennan KM; Brown RM; Roberts CW
    Insight; 1993 Apr; 18(1):8-9, 11. PubMed ID: 8509683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of action of a new anti-inflammatory analgesic drug in some eye disorders].
    Manusia M
    Minerva Oftalmol; 1967; 9(4):137-9. PubMed ID: 9082246
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of ocular inflammation with hydroxymesterone.
    Bedrossian RH
    Trans Pac Coast Otoophthalmol Soc Annu Meet; 1968; 52():185-95. PubMed ID: 5720465
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of intraocular inflammation.
    Molteno AC
    Trans Ophthalmol Soc N Z; 1980; 32():69-72. PubMed ID: 6934652
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and tolerability of a combined moxifloxacin/dexamethasone formulation for topical prophylaxis and reduction of inflammation in phacoemulsification: a comparative, double masked clinical trial.
    Freitas LL; Soriano E; Muccioli C; Höfling-Lima AL; Belfort R
    Curr Med Res Opin; 2007 Dec; 23(12):3123-30. PubMed ID: 17980093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of immunosuppressive agents in diseases of the eye.
    O'Connor GR
    Trans New Orleans Acad Ophthalmol; 1983; 31():378-81. PubMed ID: 6401148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.